286 related articles for article (PubMed ID: 19366831)
1. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
Fitzgerald LM; Kwon EM; Koopmeiners JS; Salinas CA; Stanford JL; Ostrander EA
Clin Cancer Res; 2009 May; 15(9):3231-7. PubMed ID: 19366831
[TBL] [Abstract][Full Text] [Related]
2. Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study.
Camp NJ; Farnham JM; Wong J; Christensen GB; Thomas A; Cannon-Albright LA
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1290-4. PubMed ID: 19336566
[TBL] [Abstract][Full Text] [Related]
3. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population.
Beikzadeh B; Angaji SA; Abolhasani M
BMC Med Genet; 2020 Apr; 21(1):81. PubMed ID: 32295536
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.
Ahn J; Kibel AS; Park JY; Rebbeck TR; Rennert H; Stanford JL; Ostrander EA; Chanock S; Wang MH; Mittal RD; Isaacs WB; Platz EA; Hayes RB
Clin Cancer Res; 2011 Mar; 17(5):1075-81. PubMed ID: 21343373
[TBL] [Abstract][Full Text] [Related]
5. The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients.
He Y; Gu J; Strom S; Logothetis CJ; Kim J; Wu X
Clin Cancer Res; 2014 Oct; 20(19):5133-5139. PubMed ID: 25274378
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility loci associated with prostate cancer progression and mortality.
Gallagher DJ; Vijai J; Cronin AM; Bhatia J; Vickers AJ; Gaudet MM; Fine S; Reuter V; Scher HI; Halldén C; Dutra-Clarke A; Klein RJ; Scardino PT; Eastham JA; Lilja H; Kirchhoff T; Offit K
Clin Cancer Res; 2010 May; 16(10):2819-32. PubMed ID: 20460480
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.
FitzGerald LM; Kwon EM; Conomos MP; Kolb S; Holt SK; Levine D; Feng Z; Ostrander EA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1196-203. PubMed ID: 21467234
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
[TBL] [Abstract][Full Text] [Related]
10. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P
PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317
[TBL] [Abstract][Full Text] [Related]
11. Replication of prostate cancer risk loci in a Japanese case-control association study.
Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML
J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753
[TBL] [Abstract][Full Text] [Related]
12. Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.
Lu L; Sun J; Isaacs SD; Wiley KE; Smith S; Pruett K; Zhu Y; Zhang Z; Wiklund F; Grönberg H; Walsh PC; Chang BL; Zheng SL; Isaacs WB; Xu J
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2132-6. PubMed ID: 19549809
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer susceptibility variants confer increased risk of disease progression.
Cheng I; Plummer SJ; Neslund-Dudas C; Klein EA; Casey G; Rybicki BA; Witte JS
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2124-32. PubMed ID: 20651075
[TBL] [Abstract][Full Text] [Related]
14. Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.
Jinga V; Csiki IE; Manolescu A; Iordache P; Mates IN; Radavoi D; Rascu S; Badescu D; Badea P; Mates D
J Cell Mol Med; 2016 Apr; 20(4):594-600. PubMed ID: 26773531
[TBL] [Abstract][Full Text] [Related]
15. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
[TBL] [Abstract][Full Text] [Related]
16. Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality.
Pomerantz MM; Werner L; Xie W; Regan MM; Lee GS; Sun T; Evan C; Petrozziello G; Nakabayashi M; Oh WK; Kantoff PW; Freedman ML
Cancer Prev Res (Phila); 2011 May; 4(5):719-28. PubMed ID: 21367958
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study.
Fesinmeyer MD; Kwon EM; Fu R; Ostrander EA; Stanford JL
Prostate; 2011 Oct; 71(14):1538-47. PubMed ID: 21360564
[TBL] [Abstract][Full Text] [Related]
18. Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.
Shan J; Al-Rumaihi K; Rabah D; Al-Bozom I; Kizhakayil D; Farhat K; Al-Said S; Kfoury H; Dsouza SP; Rowe J; Khalak HG; Jafri S; Aigha II; Chouchane L
J Transl Med; 2013 May; 11():121. PubMed ID: 23668334
[TBL] [Abstract][Full Text] [Related]
19. Known susceptibility SNPs for sporadic prostate cancer show a similar association with "hereditary" prostate cancer.
Cremers RG; Galesloot TE; Aben KK; van Oort IM; Vasen HF; Vermeulen SH; Kiemeney LA
Prostate; 2015 Apr; 75(5):474-83. PubMed ID: 25560306
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort.
Goh CL; Saunders EJ; Leongamornlert DA; Tymrakiewicz M; Thomas K; Selvadurai ED; Woode-Amissah R; Dadaev T; Mahmud N; Castro E; Olmos D; Guy M; Govindasami K; O'Brien LT; Hall AL; Wilkinson RA; Sawyer EJ; Al Olama AA; Easton DF; Kote-Jarai Z; Parker CC; Eeles RA
BJU Int; 2013 Sep; 112(5):666-73. PubMed ID: 23320731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]